204 related articles for article (PubMed ID: 25716285)
1. The unintended effects of the Medicare Part D low income subsidy.
Decarolis F
Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
[TBL] [Abstract][Full Text] [Related]
2. Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design?
Decarolis F
Am Econ Rev; 2015 Apr; 105(4):1547-80. PubMed ID: 29542882
[TBL] [Abstract][Full Text] [Related]
3. The Medicare drug benefit: update on the low-income subsidy.
Stahlman ME
Issue Brief George Wash Univ Natl Health Policy Forum; 2009 Jul; (833):1-22. PubMed ID: 19685590
[TBL] [Abstract][Full Text] [Related]
4. Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit.
Brill JV
Am J Health Syst Pharm; 2007 Aug; 64(15 Suppl 10):S3-6; quiz S21-S23. PubMed ID: 17646551
[TBL] [Abstract][Full Text] [Related]
5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
6. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
7. Amendments to regulations regarding eligibility for a Medicare prescription drug subsidy. Interim final rule with request for comments.
Social Security Administration
Fed Regist; 2010 Dec; 75(249):81843-6. PubMed ID: 21261125
[TBL] [Abstract][Full Text] [Related]
8. Medicare Part D subsidies. Final rules.
Social Security Administration (SSA)
Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
[TBL] [Abstract][Full Text] [Related]
9. More choice in health insurance marketplaces may reduce the value of the subsidies available to low-income enrollees.
Taylor EA; Saltzman E; Bauhoff S; Pacula RL; Eibner C
Health Aff (Millwood); 2015 Jan; 34(1):104-10. PubMed ID: 25561650
[TBL] [Abstract][Full Text] [Related]
10. Coverage for hepatitis C drugs in Medicare Part D.
Jung JK; Feldman R; Cheong C; Du P; Leslie D
Am J Manag Care; 2016 May; 22(6 Spec No.):SP220-6. PubMed ID: 27266952
[TBL] [Abstract][Full Text] [Related]
11. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
Frankenfield DL; Howell BL; Wei II; Anderson KK
Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
[TBL] [Abstract][Full Text] [Related]
12. Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.
Depue R; Stubbings J
J Manag Care Pharm; 2008; 14(1):50-60. PubMed ID: 18240882
[TBL] [Abstract][Full Text] [Related]
13. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
Thomas CP; Sussman J; ;
Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
[TBL] [Abstract][Full Text] [Related]
14. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
[TBL] [Abstract][Full Text] [Related]
15. Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?
Kanavos P; Gemmill-Toyama M
Int J Health Care Finance Econ; 2010 Sep; 10(3):203-18. PubMed ID: 20213234
[TBL] [Abstract][Full Text] [Related]
16. Who will be denied Medicare prescription drug subsidies because of the asset test?
Rice T; Desmond K
Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
[TBL] [Abstract][Full Text] [Related]
18. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
[TBL] [Abstract][Full Text] [Related]
19. Medicare program; Medicare prescription drug benefit. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
[TBL] [Abstract][Full Text] [Related]
20. Understanding the effects of Medicare Part D from key stakeholders' perspectives: Important progress, but abundant research opportunities remain.
Urmie JM; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):85-9. PubMed ID: 20511107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
